Structure and property based design of factor Xa inhibitors: Biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs

Structure and property based drug design was exploited in the synthesis of sulfonamidopyrrolidin-2-one-based factor Xa (fXa) inhibitors, incorporating basic biaryl P4 groups, producing highly potent inhibitors with significant anticoagulant activities and encouraging oral pharmacokinetic profiles. S...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry Vol. 18; no. 1; pp. 28 - 33
Main Authors: Young, Robert J., Borthwick, Alan D., Brown, David, Burns-Kurtis, Cynthia L., Campbell, Matthew, Chan, Chuen, Charbaut, Marie, Convery, Máire A., Diallo, Hawa, Hortense, Eric, Irving, Wendy R., Kelly, Henry A., King, N. Paul, Kleanthous, Savvas, Mason, Andrew M., Pateman, Anthony J., Patikis, Angela N., Pinto, Ivan L., Pollard, Derek R., Senger, Stefan, Shah, Gita P., Toomey, John R., Watson, Nigel S., Weston, Helen E., Zhou, Ping
Format: Journal Article
Language:English
Published: Oxford Elsevier Ltd 2008
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Structure and property based drug design was exploited in the synthesis of sulfonamidopyrrolidin-2-one-based factor Xa (fXa) inhibitors, incorporating basic biaryl P4 groups, producing highly potent inhibitors with significant anticoagulant activities and encouraging oral pharmacokinetic profiles. Structure and property based drug design was exploited in the synthesis of sulfonamidopyrrolidin-2-one-based factor Xa (fXa) inhibitors, incorporating basic biaryl P4 groups, producing highly potent inhibitors with significant anticoagulant activities and encouraging oral pharmacokinetic profiles.
AbstractList Structure and property based drug design was exploited in the synthesis of sulfonamidopyrrolidin-2-one-based factor Xa (fXa) inhibitors, incorporating basic biaryl P4 groups, producing highly potent inhibitors with significant anticoagulant activities and encouraging oral pharmacokinetic profiles.
Structure and property based drug design was exploited in the synthesis of sulfonamidopyrrolidin-2-one-based factor Xa (fXa) inhibitors, incorporating basic biaryl P4 groups, producing highly potent inhibitors with significant anticoagulant activities and encouraging oral pharmacokinetic profiles. Structure and property based drug design was exploited in the synthesis of sulfonamidopyrrolidin-2-one-based factor Xa (fXa) inhibitors, incorporating basic biaryl P4 groups, producing highly potent inhibitors with significant anticoagulant activities and encouraging oral pharmacokinetic profiles.
Author Zhou, Ping
Mason, Andrew M.
Young, Robert J.
Kelly, Henry A.
Kleanthous, Savvas
Senger, Stefan
Convery, Máire A.
Burns-Kurtis, Cynthia L.
Diallo, Hawa
King, N. Paul
Charbaut, Marie
Weston, Helen E.
Campbell, Matthew
Irving, Wendy R.
Pollard, Derek R.
Toomey, John R.
Pinto, Ivan L.
Brown, David
Pateman, Anthony J.
Borthwick, Alan D.
Watson, Nigel S.
Hortense, Eric
Patikis, Angela N.
Shah, Gita P.
Chan, Chuen
Author_xml – sequence: 1
  givenname: Robert J.
  surname: Young
  fullname: Young, Robert J.
  email: Rob.J.Young@gsk.com
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 2
  givenname: Alan D.
  surname: Borthwick
  fullname: Borthwick, Alan D.
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 3
  givenname: David
  surname: Brown
  fullname: Brown, David
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 4
  givenname: Cynthia L.
  surname: Burns-Kurtis
  fullname: Burns-Kurtis, Cynthia L.
  organization: GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA 19406, USA
– sequence: 5
  givenname: Matthew
  surname: Campbell
  fullname: Campbell, Matthew
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 6
  givenname: Chuen
  surname: Chan
  fullname: Chan, Chuen
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 7
  givenname: Marie
  surname: Charbaut
  fullname: Charbaut, Marie
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 8
  givenname: Máire A.
  surname: Convery
  fullname: Convery, Máire A.
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 9
  givenname: Hawa
  surname: Diallo
  fullname: Diallo, Hawa
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 10
  givenname: Eric
  surname: Hortense
  fullname: Hortense, Eric
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 11
  givenname: Wendy R.
  surname: Irving
  fullname: Irving, Wendy R.
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 12
  givenname: Henry A.
  surname: Kelly
  fullname: Kelly, Henry A.
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 13
  givenname: N. Paul
  surname: King
  fullname: King, N. Paul
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 14
  givenname: Savvas
  surname: Kleanthous
  fullname: Kleanthous, Savvas
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 15
  givenname: Andrew M.
  surname: Mason
  fullname: Mason, Andrew M.
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 16
  givenname: Anthony J.
  surname: Pateman
  fullname: Pateman, Anthony J.
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 17
  givenname: Angela N.
  surname: Patikis
  fullname: Patikis, Angela N.
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 18
  givenname: Ivan L.
  surname: Pinto
  fullname: Pinto, Ivan L.
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 19
  givenname: Derek R.
  surname: Pollard
  fullname: Pollard, Derek R.
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 20
  givenname: Stefan
  surname: Senger
  fullname: Senger, Stefan
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 21
  givenname: Gita P.
  surname: Shah
  fullname: Shah, Gita P.
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 22
  givenname: John R.
  surname: Toomey
  fullname: Toomey, John R.
  organization: GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA 19406, USA
– sequence: 23
  givenname: Nigel S.
  surname: Watson
  fullname: Watson, Nigel S.
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 24
  givenname: Helen E.
  surname: Weston
  fullname: Weston, Helen E.
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
– sequence: 25
  givenname: Ping
  surname: Zhou
  fullname: Zhou, Ping
  organization: GlaxoSmithKline, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, United Kingdom
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20037384$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18053714$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1u1DAURi1URKeFF2CBvIFdwnXs_CE2UFFAqsQCkLqzHPu69SiJg-1UmgXvjsOMYAcr-0rHR9ffd0HOZj8jIc8ZlAxY83pfDpMeywqgLRkrgfWPyI6JRhRcQH1GdtA3UHS9uD0nFzHuAZgAIZ6Qc9ZBzVsmduTn1xRWndaAVM2GLsEvGNKBDiqioQaju5upt9QqnXygt4q6-d4NLg_xDX3vVDiMdDmE4Edn3FxURd4xZkj7sPigkpvvNpnT9B4TBq8PeszD5JOz8Sl5bNUY8dnpvCTfrz98u_pU3Hz5-Pnq3U2hBatT0TfYglbQ8UY3YAxWptXYVkbztgarBqvAir4xjPEq3ztVg-n7xlZ8sPXQ80vy6ujN__uxYkxyclHjOKoZ_Rplm7NjDfs_mBHOK15nsDqCOvgYA1q5BDflNCQDubUj93JrR27tSMYk_La_ONnXYULz98mpjgy8PAEqajXaoGbt4h8uu3jLu417e-Qwh_bgMMioHc4ajQuokzTe_WuPX65qsfs
CitedBy_id crossref_primary_10_1021_jm200187y
crossref_primary_10_1016_j_ejmech_2016_05_039
crossref_primary_10_1016_j_ejmech_2011_05_056
crossref_primary_10_1134_S1070363221080120
crossref_primary_10_1080_17460441_2019_1626821
crossref_primary_10_1016_j_bioorg_2013_11_002
crossref_primary_10_1134_S1070428011080136
crossref_primary_10_1016_j_bmcl_2011_01_131
crossref_primary_10_1002_med_20183
crossref_primary_10_1002_ajoc_202100560
crossref_primary_10_1016_j_bmcl_2009_11_077
crossref_primary_10_1021_jm100146h
crossref_primary_10_1002_chem_202000617
crossref_primary_10_1021_acs_jcim_5b00523
crossref_primary_10_1021_acs_jmedchem_8b00180
crossref_primary_10_1002_ejoc_201800753
crossref_primary_10_1016_j_tips_2012_03_004
crossref_primary_10_1371_journal_pone_0220113
Cites_doi 10.1016/j.bmcl.2006.04.053
10.1016/j.bmcl.2003.12.053
10.1016/j.bmcl.2006.08.027
10.2174/1381612033453901
10.2165/00129784-200505050-00001
10.1016/j.bmcl.2007.03.080
10.1021/jm060870c
10.1016/j.bmcl.2006.09.001
10.1182/blood-2003-12-4195
10.1248/cpb.41.478
10.1246/cl.1988.899
10.2174/0929867013372643
10.1177/0091270005278084
10.1016/j.bmcl.2006.01.010
10.3987/COM-96-7489
10.1021/jm0497949
10.1002/jps.10494
ContentType Journal Article
Copyright 2007 Elsevier Ltd
2008 INIST-CNRS
Copyright_xml – notice: 2007 Elsevier Ltd
– notice: 2008 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QO
8FD
FR3
P64
7X8
DOI 10.1016/j.bmcl.2007.11.019
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList Engineering Research Database

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Chemistry
EISSN 1464-3405
1464-3391
EndPage 33
ExternalDocumentID 10_1016_j_bmcl_2007_11_019
18053714
20037384
S0960894X07013285
Genre Journal Article
GroupedDBID ---
--K
--M
.HR
.~1
0R~
1B1
1RT
1~.
1~5
23N
4.4
457
4G.
53G
5GY
5VS
6TJ
7-5
71M
8P~
9JM
9JN
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARLI
AATCM
AAXUO
ABBQC
ABFNM
ABGSF
ABJNI
ABLVK
ABMAC
ABMZM
ABTAH
ABUDA
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFS
ACIUM
ACNNM
ACRLP
ADBBV
ADECG
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AENEX
AFFNX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJSZI
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
D0L
DOVZS
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FLBIZ
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEA
HMK
HMO
HMS
HMT
HVGLF
HZ~
IHE
J1W
KOM
LCYCR
LZ2
M29
M2Z
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SCB
SCC
SDF
SDG
SDP
SES
SEW
SOC
SPC
SPCBC
SPT
SSH
SSK
SSP
SSU
SSZ
T5K
WUQ
XFK
XPP
Y6R
YK3
ZMT
ZY4
~02
~G-
ABPIF
ABPTK
IQODW
AAXKI
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
AFJKZ
CITATION
7QO
8FD
DU5
FR3
P64
UPT
7X8
ID FETCH-LOGICAL-c415t-96e70ca0836c60dde2d7ce72dc3750fabfa0f496d1132fa08a50d996f23bf5b93
ISSN 0960-894X
0968-0896
IngestDate Sun Sep 29 07:31:29 EDT 2024
Sun Sep 29 07:15:38 EDT 2024
Thu Sep 26 16:09:29 EDT 2024
Sat Sep 28 07:55:20 EDT 2024
Sun Oct 22 16:09:14 EDT 2023
Fri Feb 23 02:27:57 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Oral inhibitors
Factor Xa
Imidazole derivatives
Intravenous administration
Rat
Coagulation Factor Xa
Anticoagulant
Pyrrolidine derivatives
Thiophene derivatives
Structure activity relation
Chlorine Organic compounds
Antithrombotic agent
Chemical synthesis
Sulfonamide
Serine endopeptidases
Enzyme
Rodentia
Oral administration
Enzyme inhibitor
In vitro
Peptidases
In vivo
Vertebrata
Mammalia
Animal
Tertiary amine
Hydrolases
Benzenic compound
Fluorine Organic compounds
Pharmacokinetics
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c415t-96e70ca0836c60dde2d7ce72dc3750fabfa0f496d1132fa08a50d996f23bf5b93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 18053714
PQID 19333235
PQPubID 23462
PageCount 6
ParticipantIDs proquest_miscellaneous_70191619
proquest_miscellaneous_19333235
crossref_primary_10_1016_j_bmcl_2007_11_019
pubmed_primary_18053714
pascalfrancis_primary_20037384
elsevier_sciencedirect_doi_10_1016_j_bmcl_2007_11_019
PublicationCentury 2000
PublicationDate 2008
2008-Jan-01
2008-1-00
20080101
PublicationDateYYYYMMDD 2008-01-01
PublicationDate_xml – year: 2008
  text: 2008
PublicationDecade 2000
PublicationPlace Oxford
PublicationPlace_xml – name: Oxford
– name: England
PublicationTitle Bioorganic & medicinal chemistry
PublicationTitleAlternate Bioorg Med Chem Lett
PublicationYear 2008
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Young, Brown, Burns-Kurtis, Chan, Convery, Hubbard, Kelly, Pateman, Patikis, Senger, Shah, Tooomey, Watson, Zhou (bib10) 2007; 17
Sakamoto, Uchiyama, Kondo, Yamanaka, Uchiyama, Yabe, Kameyama, Sakamoto, Kondo, Yamanaka (bib7) 1993; 41
bib14
Pinto, Galemmo, Quan, Orwat, Clark, Li, Wells, Woerner, Alexander, Rossi, Smallwood, Wong, Luettgen, Rendina, Knabb, He, Wexler, Lam, Quan, Han, Fevig, Lam, Bai, Knabb, Luettgen, Wong, Wexler, Quan, Lam, Han, Pinto, He, Li, Ellis, Clark, Teleha, Sun, Alexander, Bai, Luettgen, Knabb, Wong, Wexler, Jia, Wu, Huang, Zhang, Clizbe, Goldman, Sinha, Arfsten, Edwards, Alphonso, Hutchaleelaha, Scarborough, Zhu (bib5) 2006; 16
bib15
bib12
bib13
Quan, Smallheer, Gould, Leadley, Hirsh, O’Donell, Weitz, Golino, Loffredo, Riegler, Renzullo, Cocchia, Alexander, Singh, McBride (bib1) 2004; 7
preceding paper.
Watson, Brown, Campbell, Chan, Chaudry, Convery, Fenwick, Hamblin, Haslam, Kelly, King, Kurtis, Leach, Manchee, Mason, Mitchell, Patel, Patel, Senger, Shah, Weston, Whitworth, Young, Chan, Borthwick, Brown, Campbell, Chaudry, Chung, Convery, Hamblin, Johnstone, Kelly, Kleanthous, Kurtis, Patikis, Patel, Pateman, Senger, Shah, Toomey, Watson, Weston, Whitworth, Young, Zhou (bib3) 2006; 16
bib9
Zhou, J. C; Confalone, P. N.; Li, H.-Y.; Oh, L. M.; Rossano, L. T.; Clark, C. G.; Teleha, C. A. WO 008199 A2, 2002.
Young, Campbell, Borthwick, Brown, Burns-Kurtis, Chan, Convery, Crowe, Dayal, Diallo, Kelly, King, Kleanthous, Mason, Mordaunt, Patel, Pateman, Senger, Shah, Smith, Watson, Weston, Zhou (bib4) 2006; 16
bib8
bib18
bib19
Young, R. J.; Borthwick, A. D.; Brown, D.; Burns-Kurtis, C. L.; Campbell, M.; Chan, C.; Charbaut, M.; Chung, C.-W.; Convery, M. A.; Kelly, H. A.; King, N. P.; Kleanthous, S.; Mason, A. M.; Pateman, A. J.; Patakis, A. N.; Pinto, I. L.; Pollard, D. R.; Senger, S.; Shah, G. P.; Toomey, J. R.; Watson, N. S.; Weston, H. E.
bib16
Valkó, Du, Bevan, Reynolds, Abraham, Valkó, Numhuck, Bevan, Abraham, Reynolds (bib11) 2001; 8
bib17
Quan (10.1016/j.bmcl.2007.11.019_bib5c) 2005; 48
Quan (10.1016/j.bmcl.2007.11.019_bib1_1) 2004; 7
Golino (10.1016/j.bmcl.2007.11.019_bib1_4) 2005; 6
10.1016/j.bmcl.2007.11.019_bib6_2
Quan (10.1016/j.bmcl.2007.11.019_bib5b) 2006; 16
Jia (10.1016/j.bmcl.2007.11.019_bib5_4) 2004; 14
Gould (10.1016/j.bmcl.2007.11.019_bib1_2) 2003; 9
Oi (10.1016/j.bmcl.2007.11.019_bib6_1) 1988; 5
Alexander (10.1016/j.bmcl.2007.11.019_bib1_5) 2005; 5
McBride (10.1016/j.bmcl.2007.11.019_bib1_6) 2005; 45
Uchiyama (10.1016/j.bmcl.2007.11.019_bib7_2) 1996; 43
10.1016/j.bmcl.2007.11.019_bib2
Chan (10.1016/j.bmcl.2007.11.019_bib3b) 2007; 50
Young (10.1016/j.bmcl.2007.11.019_bib4) 2006; 16
Pinto (10.1016/j.bmcl.2007.11.019_bib5a) 2006; 16
Valkó (10.1016/j.bmcl.2007.11.019_bib11b) 2003; 92
Sakamoto (10.1016/j.bmcl.2007.11.019_bib7_1) 1993; 41
Valkó (10.1016/j.bmcl.2007.11.019_bib11a) 2001; 8
Watson (10.1016/j.bmcl.2007.11.019_bib3_1) 2006; 16
Young (10.1016/j.bmcl.2007.11.019_bib10) 2007; 17
Hirsh (10.1016/j.bmcl.2007.11.019_bib1_3) 2005; 105
References_xml – ident: bib17
– ident: bib16
– ident: bib14
– volume: 8
  start-page: 1137
  year: 2001
  ident: bib11
  publication-title: Curr. Med. Chem.
  contributor:
    fullname: Reynolds
– ident: bib15
– volume: 16
  start-page: 3784
  year: 2006
  ident: bib3
  publication-title: Bioorg. Med. Chem. Lett.
  contributor:
    fullname: Zhou
– ident: bib18
– ident: bib9
– ident: bib19
– ident: bib13
– ident: bib12
– volume: 16
  start-page: 5953
  year: 2006
  ident: bib4
  publication-title: Bioorg. Med. Chem. Lett.
  contributor:
    fullname: Zhou
– volume: 17
  start-page: 2927
  year: 2007
  ident: bib10
  publication-title: Bioorg. Med. Chem. Lett.
  contributor:
    fullname: Zhou
– volume: 7
  start-page: 460
  year: 2004
  ident: bib1
  publication-title: Curr. Opin. Drug Discov. Dev.
  contributor:
    fullname: McBride
– ident: bib8
– volume: 41
  start-page: 478
  year: 1993
  ident: bib7
  publication-title: Chem. Pharm. Bull.
  contributor:
    fullname: Yamanaka
– volume: 16
  start-page: 5584
  year: 2006
  ident: bib5
  publication-title: Bioorg. Med. Chem. Lett.
  contributor:
    fullname: Zhu
– volume: 16
  start-page: 3784
  year: 2006
  ident: 10.1016/j.bmcl.2007.11.019_bib3_1
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2006.04.053
  contributor:
    fullname: Watson
– volume: 6
  start-page: 298
  year: 2005
  ident: 10.1016/j.bmcl.2007.11.019_bib1_4
  publication-title: Curr. Opin. Invest. Drugs
  contributor:
    fullname: Golino
– volume: 14
  start-page: 1221
  year: 2004
  ident: 10.1016/j.bmcl.2007.11.019_bib5_4
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2003.12.053
  contributor:
    fullname: Jia
– volume: 16
  start-page: 5584
  year: 2006
  ident: 10.1016/j.bmcl.2007.11.019_bib5a
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2006.08.027
  contributor:
    fullname: Pinto
– volume: 9
  start-page: 2337
  year: 2003
  ident: 10.1016/j.bmcl.2007.11.019_bib1_2
  publication-title: J. Curr. Pharm. Des.
  doi: 10.2174/1381612033453901
  contributor:
    fullname: Gould
– volume: 5
  start-page: 279
  year: 2005
  ident: 10.1016/j.bmcl.2007.11.019_bib1_5
  publication-title: Am. J. Cardiovasc. Drugs
  doi: 10.2165/00129784-200505050-00001
  contributor:
    fullname: Alexander
– ident: 10.1016/j.bmcl.2007.11.019_bib2
– volume: 17
  start-page: 2927
  year: 2007
  ident: 10.1016/j.bmcl.2007.11.019_bib10
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2007.03.080
  contributor:
    fullname: Young
– volume: 7
  start-page: 460
  year: 2004
  ident: 10.1016/j.bmcl.2007.11.019_bib1_1
  publication-title: Curr. Opin. Drug Discov. Dev.
  contributor:
    fullname: Quan
– volume: 50
  start-page: 1546
  year: 2007
  ident: 10.1016/j.bmcl.2007.11.019_bib3b
  publication-title: J. Med. Chem.
  doi: 10.1021/jm060870c
  contributor:
    fullname: Chan
– volume: 16
  start-page: 5953
  year: 2006
  ident: 10.1016/j.bmcl.2007.11.019_bib4
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2006.09.001
  contributor:
    fullname: Young
– volume: 105
  start-page: 453
  year: 2005
  ident: 10.1016/j.bmcl.2007.11.019_bib1_3
  publication-title: Blood
  doi: 10.1182/blood-2003-12-4195
  contributor:
    fullname: Hirsh
– volume: 41
  start-page: 478
  year: 1993
  ident: 10.1016/j.bmcl.2007.11.019_bib7_1
  publication-title: Chem. Pharm. Bull.
  doi: 10.1248/cpb.41.478
  contributor:
    fullname: Sakamoto
– ident: 10.1016/j.bmcl.2007.11.019_bib6_2
– volume: 5
  start-page: 899
  year: 1988
  ident: 10.1016/j.bmcl.2007.11.019_bib6_1
  publication-title: Chem. Lett.
  doi: 10.1246/cl.1988.899
  contributor:
    fullname: Oi
– volume: 8
  start-page: 1137
  year: 2001
  ident: 10.1016/j.bmcl.2007.11.019_bib11a
  publication-title: Curr. Med. Chem.
  doi: 10.2174/0929867013372643
  contributor:
    fullname: Valkó
– volume: 45
  start-page: 1004
  year: 2005
  ident: 10.1016/j.bmcl.2007.11.019_bib1_6
  publication-title: J. Clin. Pharmacol.
  doi: 10.1177/0091270005278084
  contributor:
    fullname: McBride
– volume: 16
  start-page: 1795
  year: 2006
  ident: 10.1016/j.bmcl.2007.11.019_bib5b
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2006.01.010
  contributor:
    fullname: Quan
– volume: 43
  start-page: 1301
  year: 1996
  ident: 10.1016/j.bmcl.2007.11.019_bib7_2
  publication-title: Heterocycles
  doi: 10.3987/COM-96-7489
  contributor:
    fullname: Uchiyama
– volume: 48
  start-page: 1729
  year: 2005
  ident: 10.1016/j.bmcl.2007.11.019_bib5c
  publication-title: J. Med. Chem.
  doi: 10.1021/jm0497949
  contributor:
    fullname: Quan
– volume: 92
  start-page: 2236
  year: 2003
  ident: 10.1016/j.bmcl.2007.11.019_bib11b
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.10494
  contributor:
    fullname: Valkó
SSID ssj0014044
ssj0002491
Score 2.0451984
Snippet Structure and property based drug design was exploited in the synthesis of sulfonamidopyrrolidin-2-one-based factor Xa (fXa) inhibitors, incorporating basic...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 28
SubjectTerms Animals
Anticoagulants - chemistry
Anticoagulants - pharmacokinetics
Anticoagulants - pharmacology
Biological and medical sciences
Blood. Blood coagulation. Reticuloendothelial system
Bridged Bicyclo Compounds, Heterocyclic - chemistry
Bridged Bicyclo Compounds, Heterocyclic - pharmacokinetics
Bridged Bicyclo Compounds, Heterocyclic - pharmacology
Factor Xa
Factor Xa Inhibitors
Hydrophobic and Hydrophilic Interactions
Male
Medical sciences
Models, Molecular
Oral inhibitors
Pharmacology. Drug treatments
Pyrrolidinones - chemistry
Pyrrolidinones - pharmacokinetics
Pyrrolidinones - pharmacology
Rats
Rats, Sprague-Dawley
Serine Proteinase Inhibitors - chemistry
Serine Proteinase Inhibitors - pharmacokinetics
Serine Proteinase Inhibitors - pharmacology
Stereoisomerism
Structure-Activity Relationship
Title Structure and property based design of factor Xa inhibitors: Biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs
URI https://dx.doi.org/10.1016/j.bmcl.2007.11.019
https://www.ncbi.nlm.nih.gov/pubmed/18053714
https://search.proquest.com/docview/19333235
https://search.proquest.com/docview/70191619
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELa6XQmQEIIuj_JYfEBcIldu3uFWdouW5XHpIvUWOU6szaqbVk176IH_zoydR0spAiQuVZS2iaPvy3hmPP6GkDfgUnOYxlLm8yBlrp1KFiXZkDlhJv0w4okrcTfyxST4Og3Px-6406mbr7bn_ivScA6wxp2zf4F2c1E4AceAOXwC6vD5R7hPtCBsvSywwFz7EhxtnK1SK9X1Guggmj471lRYeXGdJzk23cHswPtcLDcza7FZYjsfmNiYzVDO30IVByN6jMkFuJwWxwZU5nIjUSkbq_pUubNInM9N0yipCVYt46MgSd1lzprp3UTlnu0xBd_W5aBJF2y3fR_NwCqdt9_VqYStAn29QaMo2ac1tpvW6eBNsbrOhfV5sJPpCNvEW735pq100hlMn7MwMgWeg8zYb9d3meNy79cGviFyZa3DrXnf6HHszSgmuXEzSG7lzCheouhrZeZ3lbonOCIcEJhRCPJD74gc22D_7C45Hn0cTy-b5S2X6y7DzRNUu7lM4eHPdzrkMd1fiBLeY2UasByOkLSndPWQPKhCHDoy3HxEOlnRIyejQqzmtxv6luqiY72a0yN3z2oq9MidL1Wdxwn53rCYAotpzWKqWUwNi-lcUcNiOhW0ZfE7ajhM9zhMdzhMNYfpNoep4fBj8u3D-OrsglWNQpgE_3PFIj8LuBQotC59DhO2nQYyC8DwOOAQK5EowZUb-ekQYIHjUHg8hUBf2U6ivCRynpBuAeN4RqiXhVwprsCLjsBvs4WTKpkAXAlcPRuqPrFqMOKF0YOJ60LJmxihw8auAQTWMUDXJ16NV1x5tMZTjYFev_3f6Q64za2wlDRwQrdPXtdox4ASLvKJIpuvyxgCMsexHe_wL7ABA8R5cJOnhibtg4So7jR0n__jsF-Qe6acCjOUL0kXqJK9Ikdluj6t3oAfgxPzxQ
link.rule.ids 315,782,786,4028,27932,27933,27934
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structure+and+property+based+design+of+factor+Xa+inhibitors%3A+Biaryl+pyrrolidin-2-ones+incorporating+basic+heterocyclic+motifs&rft.jtitle=Bioorganic+%26+medicinal+chemistry+letters&rft.au=Young%2C+Robert+J.&rft.au=Borthwick%2C+Alan+D.&rft.au=Brown%2C+David&rft.au=Burns-Kurtis%2C+Cynthia+L.&rft.date=2008&rft.pub=Elsevier+Ltd&rft.issn=0960-894X&rft.eissn=1464-3405&rft.volume=18&rft.issue=1&rft.spage=28&rft.epage=33&rft_id=info:doi/10.1016%2Fj.bmcl.2007.11.019&rft.externalDocID=S0960894X07013285
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-894X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-894X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-894X&client=summon